Skip to main content

Table 2 Multivariate analysis of prognostic factors affecting locoregional control in patients with nasopharyngeal carcinoma

From: Intensity-modulated radiotherapy with simultaneous modulated accelerated boost technique and chemotherapy in patients with nasopharyngeal carcinoma

Prognostic factor

Hazard ratio

95% CI

p-value

Age groups (years)

   

Below 40

1.1

0.8-1.4

0.07

Above 40

1.0

-

0.9

Gender

   

Male

1.0

-

0.9

Female

1.0

-

 

T stage

   

T1 and T2

1.8

1.3-2.2

0.04

T3 and T4

4.2

3.8-4.6

0.0001

N stage

   

N0 and N1

0.8

0.6-1.0

0.04

N2 and N3

3.8

3.4-4.2

0.001

EBV status

   

Positive

0.7

0.8-1.4

0.002

Negative

1.8

1.3-2.2

0.04

  1. Abbreviations: T tumor, N node, EBV Epstein-Barr virus.